Literature DB >> 10668342

[Possible genetic causes for late complications of diabetes mellitus].

T Klemm1, R Paschke.   

Abstract

BACKGROUND: Hyperglycemia occurs in every patient with diabetes mellitus. It is the most important factor in the development of diabetic complications. However, the onset, intensity and the progression of complications show large interindividual variations. Manifestation in families and the lack of complications in some diabetics with poor metabolic control indicate a genetic predisposition to develop diabetic complications like nephropathy, neuropathy and angiopathy. NEPHROPATHY: Diabetic nephropathy occurs only in 25 to 40% of the diabetic patients. Therefore a genetic risk factor for this complication is very likely. Various variations in genes like ACE-gene and angiotensinogen-gene have been described, which could be associated with the development of diabetic nephropathy. NEUROPATHY: Peripheral diabetic neuropathy occurs in up to 66% of all diabetics. Therefore and because of the possible pathological mechanisms genetic risk factors like variations in the Na/K-ATPase-gene and in the aldose reductase-gene are discussed. RETINOPATHY: An association between diabetic retinopathy and polymorphisms in the ACE-gene and the aldose reductase-gene seems very unlikely, because up to 75% of the diabetic patients suffer from retinopathy after 15 years of diabetes. MACROANGIOPATHY: A large number of studies show an association between diabetic macroangiopathy and genetic variations in the ACE-gene (I/D-variant) and the paraoxonase-gene (2 isoforms).
CONCLUSION: Based on the current evidence for associations of genetic markers with diabetic complications, the generation of an individual risk profile based on genetic markers seems to be possible. In addition to near euglycemia genetic markers could direct therapeutic strategies and lead to new therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10668342     DOI: 10.1007/bf03044978

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  84 in total

1.  Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group.

Authors:  G Imperatore; R L Hanson; D J Pettitt; S Kobes; P H Bennett; W C Knowler
Journal:  Diabetes       Date:  1998-05       Impact factor: 9.461

2.  The association between a family history of type 2 diabetes and coronary artery disease in a type 1 diabetes population.

Authors:  J R Erbey; L H Kuller; D J Becker; T J Orchard
Journal:  Diabetes Care       Date:  1998-04       Impact factor: 19.112

Review 3.  Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  G Panzram
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

4.  Activated protein C resistance in type I diabetes.

Authors:  G Gruden; C Olivetti; P Cavallo-Perin; M Bazzan; S Stella; G Tamponi; G Pagano
Journal:  Diabetes Care       Date:  1997-03       Impact factor: 19.112

Review 5.  Hyperglycemia and cardiovascular disease in type 2 diabetes.

Authors:  M Laakso
Journal:  Diabetes       Date:  1999-05       Impact factor: 9.461

6.  Synergistic effect of angiotensin II type 1 receptor genotype and poor glycaemic control on risk of nephropathy in IDDM.

Authors:  A Doria; T Onuma; J H Warram; A S Krolewski
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

7.  Treatment of diabetic autonomic neuropathy with an aldose reductase inhibitor.

Authors:  T J Faes; G A Yff; O DeWeerdt; P Lanting; J J Heimans; F W Bertelsmann
Journal:  J Neurol       Date:  1993       Impact factor: 4.849

8.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

9.  The molecular basis of the human serum paraoxonase activity polymorphism.

Authors:  R Humbert; D A Adler; C M Disteche; C Hassett; C J Omiecinski; C E Furlong
Journal:  Nat Genet       Date:  1993-01       Impact factor: 38.330

10.  An (A-C)n dinucleotide repeat polymorphic marker at the 5' end of the aldose reductase gene is associated with early-onset diabetic retinopathy in NIDDM patients.

Authors:  B C Ko; K S Lam; N M Wat; S S Chung
Journal:  Diabetes       Date:  1995-07       Impact factor: 9.461

View more
  2 in total

1.  Distribution of glyoxalase I polymorphism among Zuni Indians: the Zuni Kidney Project.

Authors:  Guenet H Degaffe; David L Vander Jagt; Arlene Bobelu; Jeanette Bobelu; Donica Neha; Mildred Waikaniwa; Philip Zager; Vallabh O Shah
Journal:  J Diabetes Complications       Date:  2008-04-16       Impact factor: 2.852

2.  WenTong HuoXue Cream Can Inhibit the Reduction of the Pain-Related Molecule PLC-β3 in the Dorsal Root Ganglion of a Rat Model of Diabetic Peripheral Neuropathy.

Authors:  Chengcheng Feng; Lijuan Xu; Shiyun Guo; Qian Chen; Yuguo Shen; Deng Zang; Li Ma
Journal:  Evid Based Complement Alternat Med       Date:  2018-02-11       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.